Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation

被引:243
作者
Kuwana, M
Okazaki, Y
Kodama, H
Izumi, K
Yasuoka, H
Ogawa, Y
Kawakami, Y
Ikeda, Y
机构
[1] Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan
[3] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan
关键词
fibronectin; lineage; mesenchymal stem cell; plasticity;
D O I
10.1189/jlb.0403170
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circulating CD14(+) monocytes are precursors of phagocytes, such as macrophages and dendritic cells. Here we report primitive cells with a fibroblast-like morphology derived from human peripheral blood CD14(+) monocytes that can differentiate into several distinct mesenchymal cell lineages. We named this cell population monocyte-derived mesenchymal progenitor (MOMP). MOMPs were obtained in vitro from human peripheral blood mononuclear cells cultured on fibronectin in the presence of fetal bovine serum alone as a source of growth factors. MOMPs had a unique molecular phenotype-CD14(+)CD45(+)CD34(+) type I collagen(+)-and showed mixed morphologic and molecular features of monocytes and endothelial and mesenchymal cells. MOMPs were found to he derived from a subset of circulating CD14(+) monocytes, and their differentiation required that they bind fibronectin and be exposed to one or more soluble factors derived from peripheral blood CD14(-) cells. MOMPs could be expanded in culture without losing their original phenotype for up to five passages. The induction of MOMPs to differentiate along multiple limb-bud mesodermal lineages resulted in the expression of genes and proteins specific for osteoblasts, skeletal myoblasts, chondrocytes, and adipocytes. Our findings represent the first evidence that human circulating CD14(+) monocytes are a source of progenitors that exhibit mesenchymal cell differentiation.
引用
收藏
页码:833 / 845
页数:13
相关论文
共 47 条
[1]   Hepatic stem cells [J].
Alison, M ;
Sarraf, C .
JOURNAL OF HEPATOLOGY, 1998, 29 (04) :676-682
[2]   Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[3]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[4]   The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105) [J].
Barry, FP ;
Boynton, RE ;
Haynesworth, S ;
Murphy, JM ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :134-139
[5]   Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood [J].
Bender, A ;
Sapp, M ;
Schuler, G ;
Steinman, RM ;
Bhardwaj, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :121-135
[6]   Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[7]   Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow [J].
Campagnoli, C ;
Roberts, IAG ;
Kumar, S ;
Bennett, PR ;
Bellantuono, I ;
Fisk, NM .
BLOOD, 2001, 98 (08) :2396-2402
[8]  
CAMPANA D, 1988, BLOOD, V71, P1201
[9]   Mineralization and the expression of matrix proteins during in vivo bone development [J].
Cowles, EA ;
DeRome, ME ;
Pastizzo, G ;
Brailey, LL ;
Gronowicz, GA .
CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (01) :74-82
[10]  
De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO